Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)

INDIGO Biosciences, Inc. is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making. They supplement the world's largest portfolio of cell-based nuclear receptor kits and services and in vitro toxicology solutions with great results readability, reproducibility, and faster turnaround times.